Similarly SOX17 has been shown to be involved in other cellular pathways important to PAH pathogenesis such as cyclin, VEGF, Wnt/B-catenin, and endothelin signaling in the context of embryonic and arterial development. This evidence concerns the gene VEGFA and pulmonary arterial hypertension.